GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SunLink Health Systems Inc (AMEX:SSY) » Definitions » Risk Assessment

SunLink Health Systems (SunLink Health Systems) Risk Assessment


View and export this data going back to 1990. Start your Free Trial

What is SunLink Health Systems Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of SunLink Health Systems is: High Risk: High uncertainty.


Competitive Comparison of SunLink Health Systems's Risk Assessment

For the Pharmaceutical Retailers subindustry, SunLink Health Systems's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SunLink Health Systems's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SunLink Health Systems's Risk Assessment distribution charts can be found below:

* The bar in red indicates where SunLink Health Systems's Risk Assessment falls into.



SunLink Health Systems  (AMEX:SSY) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


SunLink Health Systems Risk Assessment Related Terms

Thank you for viewing the detailed overview of SunLink Health Systems's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


SunLink Health Systems (SunLink Health Systems) Business Description

Traded in Other Exchanges
N/A
Address
900 Circle 75 Parkway, Suite 690, Atlanta, GA, USA, 30339
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operates nearly 80-licensed-bed, acute care hospitals, which includes more than 18-bed geriatric psychology unit, and over 60-bed nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
Executives
Howard E Turner director 135 PROVIDENCE OAKS POINTE, MILTON GA 30004
Thornton Robert M Jr director, officer: CEO & Chairman 900 CIRCLE 75 PARKWAY, SUITE 690, ATLANTA GA 30339
C Michael Ford director 310 NORRIS STREET, ST. MARYS GA 31558
Mills Christopher H B director 6 STRATTON STREET, MAYFAIR, LONDON X0 W1J 8LD
Steven J Baileys director 30691 HUNT CLUB DRIVE, SAN JUAN CAPISTRANO CA 92675
Sheila G. Brockman officer: CEO So Health Corp of Houston 900 CIRCLE 75 PARKWAY, SUITE 690, ATLANTA GA 30339
Mark J Stockslager officer: Corporate Controller and PAO 900 CIRCLE 75 PARKWAY STE. 690, ATLANTA GA 30339
Karen B Brenner director P.O. BOX 9109, NEWPORT BEACH CA 92658
Gene E Burleson director 320 ARGONNE DR, ATLANTA GA 30305-2814
A Ronald Turner officer: Chief Operating Officer 900 CIRCLE 75 PARKWAY, SUITE 1120, ATLANTA GA 30339
Harry R Alvis officer: Chief Operating Officer 900 CIRCLE 75 PARKWAY STE. 1120, ATLANTA GA 30339
George D. Shaunnessy other: Pres/CEO Sunlink Homecare Svcs 900 CIRCLE 75 PARKWAY, SUITE 1120, ATLANTA GA 30339
Jack M. Spurr officer: VP, Hospital Financial Ops. 900 CIRCLE 75 PARKWAY, SUITE 1120, ATLANTA GA 30339
Michael William Hall director 3406 RAVENWOOD LANE, MIRAMAR BEACH FL 32550
North Atlantic Value Llp 10 percent owner RYDER COURT, 14 RYDER ST., LONDON A1 00000